REQUEST A DEMO
Total
USD $0.00
Search more companies

Glaxosmithkline Biologicals Kft. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: GlaxoSmithKline Biologicals Gyogyszergyarto es Forgalmazo Kft. Profile Updated: November 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Glaxosmithkline Biologicals Kft. is a company based in Hungary, with its head office in Godollo. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on July 09, 2001. 325 (2023) employees currently work for Glaxosmithkline Biologicals Kft.. In its most recent financial highlights, the company reported a net sales revenue increase of 18.53% in 2022. There was a total negative growth of 2.33% in Glaxosmithkline Biologicals Kft.’s total assets over the same period. In 2022, Glaxosmithkline Biologicals Kft.’s net profit margin increased by 2.09%.

Headquarters
Homoki Nagy Istvan utca 1.
Godollo; Pest; Postal Code: 2100

Contact Details: Purchase the Glaxosmithkline Biologicals Kft. report to view the information.

Website: http://www.gsk.hu

Basic Information
Total Employees:
Purchase the Glaxosmithkline Biologicals Kft. report to view the information.
Outstanding Shares:
Purchase the Glaxosmithkline Biologicals Kft. report to view the information.
Registered Capital:
Purchase the Glaxosmithkline Biologicals Kft. report to view the information.
Financial Auditors:
Purchase the Glaxosmithkline Biologicals Kft. report to view the information.
Incorporation Date:
July 09, 2001
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Glaxosmithkline Biologicals Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
18.53%
Total operating revenue
18.15%
Operating profit (EBIT)
-10.18%
EBITDA
8.43%
Net Profit (Loss) for the Period
33.15%
Total assets
-2.33%
Total equity
-3.99%
Operating Profit Margin (ROS)
-4.04%
Net Profit Margin
2.09%
Return on Equity (ROE)
1.81%
Quick Ratio
-0.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?